Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September

GIACOMIN, SMITH REELECTED TO LEAD HDA BOARD OF DIRECTORS

The Healthcare Distribution Alliance (HDA) announced Jon Giacomin, Chief Executive Officer, Pharmaceutical segment, Cardinal Health, will serve a second term as Chairman of the HDA Board of Directors. Mr. Giacomin’s reelection was announced at the HDA Annual Board and Membership Meeting. Henry Dale Smith, Jr., Chairman and CEO, H. D. Smith Holding Company, also was reelected to serve as Vice Chairman.

This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.

HDA President and CEO John M. Gray said, “HDA is pleased to welcome back Jon and Dale —their steady leadership will help shape the Alliance’s efforts to promote the critical role of pharmaceutical distributors, whose expertise ensures the safety and efficiency of the supply chain every day.”

Additionally, the Alliance announced the following appointments to the Board of Directors:

  • Fred Battah, CEO, HPC Rx;
  • Earl English, President, CuraScript SD;
  • Michael Holmes, CEO Principal Dynamics and CEO QCP, Quality Care Products LLC.

Further details on the HDA Board of Directors’ responsibilities and a full listing of its members are available on the Alliance website.

List: Digitalization Companies From PACK EXPO
Looking for CPG-focused digital transformation solutions? Download our editor-curated list from PACK EXPO featuring top companies offering warehouse management, ERP, digital twin, and MES software with supply chain visibility and analytics capabilities—all tailored specifically for CPG operations.
Download Now
List: Digitalization Companies From PACK EXPO
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?